Federation Des Caisses Desjardins Du Quebec Moderna, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Moderna, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 31,345 shares of MRNA stock, worth $894,586. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,345
Previous 31,069
0.89%
Holding current value
$894,586
Previous $2.08 Million
37.24%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding MRNA
# of Institutions
918Shares Held
253MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.15 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.11 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$730 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$502 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$209 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...